OTCMKTS:ISOLF Isodiol International Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Isodiol International Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.03 0.00 (0.00 %) (As of 09/25/2020 12:00 AM ET) Add Compare Share Today's Range$0.03Now: $0.03▼$0.0350-Day Range$0.02MA: $0.03▼$0.0452-Week Range$0.01Now: $0.03▼$0.29Volume1,108 shsAverage Volume103,197 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileChartCompetitorsHeadlinesShort InterestSocial Media Isodiol International, Inc. engages in the development cannabinoid-based pharmaceuticals and consumer products. The firm operates through the following segments: Canada, United States, and United Kingdom. Its services also include the research, education, development, and manufacturing of cannabinoid products. Its products include Bulk CBD, Bioactive CBD, Pot-O-Coffee, Cannaceuticals CBD Skincare, Iso-Sport, CBD Xtreme, Isoderm, Aquavita CBD water, Bradley's Brand, and Kathy Ireland Health and Wellness. The company was founded on June 2, 2014 and is headquartered in Vancouver, Canada.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Isodiol International. Previous Next 2.0 Community Rank Outperform VotesIsodiol International has received 29 “outperform” votes. (Add your “outperform” vote.)Underperform VotesIsodiol International has received 42 “underperform” votes. (Add your “underperform” vote.)Community SentimentIsodiol International has received 59.15% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Isodiol International and other stocks. Vote “Outperform” if you believe ISOLF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ISOLF will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldIsodiol International does not currently pay a dividend.Dividend GrowthIsodiol International does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Isodiol International insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.40 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:ISOLF Previous Symbol CUSIPN/A CIKN/A Webisodiol.com PhoneN/ADebt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees57 Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable $0.03 0.00 (0.00 %) (As of 09/25/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive ISOLF News and Ratings via Email Sign-up to receive the latest news and ratings for ISOLF and its competitors with MarketBeat's FREE daily newsletter. Isodiol International (OTCMKTS:ISOLF) Frequently Asked Questions How has Isodiol International's stock been impacted by Coronavirus (COVID-19)? Isodiol International's stock was trading at $0.09 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ISOLF shares have decreased by 72.1% and is now trading at $0.0251. View which stocks have been most impacted by COVID-19. Are investors shorting Isodiol International? Isodiol International saw a decrease in short interest in the month of August. As of August 31st, there was short interest totaling 11,200 shares, a decrease of 26.8% from the August 15th total of 15,300 shares. Based on an average trading volume of 117,100 shares, the short-interest ratio is currently 0.1 days. View Isodiol International's Short Interest. Who are some of Isodiol International's key competitors? Some companies that are related to Isodiol International include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Althea Group (AGH), Applied Biosciences (APPB), Auscann Group (AC8), Ayr Strategies (AYRSF), Biome Grow (BIO), Blueberries Medical (BBM), Canbiola (CANB), Cannara Biotech (LOVE), Cannpal Animal Therapeutics (CP1), Cansortium (CNTMF) and Charlotte's Web (CWBHF). View all competitors. Who are Isodiol International's key executives? Isodiol International's management team includes the following people: Marcos Agramont, President, Chief Executive Officer & DirectorPatrick Ogle, Chief Operating Officer & DirectorEli Dusenbury, Chief Financial OfficerMarvin Washington, Director & Vice President-Business DevelopmentKevin Swadish, Chief Revenue Officer What is Isodiol International's stock symbol? Isodiol International trades on the OTCMKTS under the ticker symbol "ISOLF." How do I buy shares of Isodiol International? Shares of ISOLF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Isodiol International's stock price today? One share of ISOLF stock can currently be purchased for approximately $0.03. What is Isodiol International's official website? The official website for Isodiol International is isodiol.com. This page was last updated on 9/26/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
